TCI Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
TCI Wealth Advisors's BMY Position: Q2 2026 in Review
TCI Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 0.24% in Q2 2026, selling an estimated $632 and leaving 4,558 shares worth $263K. The position accounts for 0.01% of the portfolio, ranked #228.
TCI Wealth Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.71M in Q2 2016. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- TCI Wealth Advisors held 4,558 shares of Bristol-Myers Squibb worth $263K as of Q2 2026.
- TCI Wealth Advisors sold 11 Bristol-Myers Squibb shares in Q2 2026, an estimated $632.
- Bristol-Myers Squibb made up 0.01% of TCI Wealth Advisors's portfolio in Q2 2026, its #228 holding.
- TCI Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- TCI Wealth Advisors's Bristol-Myers Squibb position peaked at $2.71M in Q2 2016.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on TCI Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.